HER2 Positivity Predicts Unresponsiveness to EGFR‐Targeted Treatment in Metastatic Colorectal Cancer
Oncologist - United States
doi 10.1634/theoncologist.2018-0785
Full Text
Open PDFAbstract
Available in full text
Date
April 5, 2019
Authors
Publisher
Alphamed Press